Next Article in Journal
Gradient Material Strategies for Hydrogel Optimization in Tissue Engineering Applications
Previous Article in Journal
Application of High-Throughput Assays to Examine Phospho-Modulation of the Late Steps of Regulated Exocytosis
Previous Article in Special Issue
Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay
Please note that, as of 21 September 2020, High-Throughput has been renamed to BioTech and is now published here.

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

NMI Natural and Medical Sciences Institute at the University of Tuebingen, 72770 Reutlingen, Germany
Department of Neurology, University of Ulm, 89081 Ulm, Germany
German Centre for Diabetes Research (DZD), 72076 Tübingen, Germany
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, 72076 Tübingen, Germany
Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Tübingen University Hospital, 72076 Tübingen, Germany
Author to whom correspondence should be addressed.
Academic Editor: Massimo Negrini
High-Throughput 2017, 6(4), 18;
Received: 20 October 2017 / Revised: 8 November 2017 / Accepted: 13 November 2017 / Published: 16 November 2017
(This article belongs to the Special Issue Protein Microarrays)
Procalcitonin (PCT) is well established as a highly specific biomarker for the detection of bacterial infections and sepsis. However, the currently available diagnostic tests are not able to detect very low or very early increases of PCT or even baseline levels in healthy individuals or patients with non-bacterial infections. In order to be able to detect these very low concentrations of PCT, a sandwich immunoassay was developed using high sensitivity Single Molecule Array technology (Simoa). The assay was thoroughly validated and applied to analyze human cerebrospinal fluid (CSF) and serum samples from patients with bacterial or viral meningitis as well as CSF, serum, and K2 EDTA plasma from healthy control subjects. A 50-fold increase in sensitivity compared to the current gold standard assays was achieved, which was sensitive enough for the detection of baseline PCT levels. Both serum and CSF showed significantly elevated PCT levels in patients with bacterial meningitis compared to patients with viral meningitis and the healthy control group. Procalcitonin concentration levels for patients with viral meningitis and the control group could be measured, but were not significantly different. The determination of PCT in the low pg·mL−1 range could help to improve the monitoring of bacterial infectious diseases, as PCT level changes could be detected earlier. View Full-Text
Keywords: single molecule array; validation; procalcitonin; base line level single molecule array; validation; procalcitonin; base line level
Show Figures

Figure 1

MDPI and ACS Style

Carcamo Yañez, V.A.; Göpfert, J.C.; Otto, M.; Tumani, H.; Peter, A.; Joos, T.O. Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay. High-Throughput 2017, 6, 18.

AMA Style

Carcamo Yañez VA, Göpfert JC, Otto M, Tumani H, Peter A, Joos TO. Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay. High-Throughput. 2017; 6(4):18.

Chicago/Turabian Style

Carcamo Yañez, Viviana A., Jens C. Göpfert, Markus Otto, Hayrettin Tumani, Andreas Peter, and Thomas O. Joos. 2017. "Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay" High-Throughput 6, no. 4: 18.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop